4 Alzheimers Disease Clinical Trials in Auburn, CA (2026)

Q: How do I join a clinical trial in Auburn?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Auburn research site will contact you.

Recruiting Alzheimers Disease Studies in Auburn

NCT02693535Recruiting

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

The purpose of the study is to learn from the real world practice of prescribing targeted therapies to patients with advanced cancer whose tumor harbors a genomic variant known to be a drug target or ...

Auburn, CAPHASE24,200 participantsAmerican Society of Clinical Oncology

View Study Details

NCT01810913Recruiting

Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

This phase II/III trial studies how well radiation therapy works when given together with cisplatin, docetaxel, cetuximab, and/or atezolizumab after surgery in treating patients with high-risk stage I...

Auburn, CAPHASE2613 participantsNational Cancer Institute (NCI)

View Study Details

NCT03180268Recruiting

Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery

This randomized phase III trial studies how well radiation therapy works compared with observation in treating patients with newly diagnosed grade II meningioma that has been completely removed by sur...

Auburn, CAPHASE3163 participantsNRG Oncology

View Study Details

NCT06998940Recruiting

Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations

This phase III trial compares the effect of adding panitumumab to standard chemotherapy (with nanoliposomal Irinotecan, leucovorin, and 5-fluorouracil \[5-FU\] or irinotecan, leucovorin, and 5-FU or n...

Auburn, CAPHASE394 participantsSWOG Cancer Research Network

View Study Details

About Alzheimers Disease Clinical Trials in Auburn

Alzheimer's disease is a progressive brain disorder that destroys memory, thinking skills, and the ability to carry out daily tasks. It is the most common cause of dementia, affecting over 6.7 million Americans age 65 and older. The disease is characterized by amyloid-beta plaques and tau tangles in the brain. Recent FDA approvals of anti-amyloid antibodies like lecanemab (Leqembi) and donanemab have opened a new era of disease-modifying treatments. Clinical trials are now exploring next-generation amyloid-clearing therapies, tau-targeting treatments, anti-inflammatory approaches, and combination strategies. Early-stage patients with mild cognitive impairment or early Alzheimer's are frequently sought for enrollment, and many trials now use blood-based biomarkers for screening.

There are currently 4 alzheimers disease clinical trials recruiting participants in Auburn, CA. These studies are seeking a combined 5,070 participants. Research is being sponsored by American Society of Clinical Oncology, National Cancer Institute (NCI), NRG Oncology and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Alzheimers Disease Clinical Trials in Auburn — FAQ

Are there alzheimers disease clinical trials in Auburn?

Yes, there are 4 alzheimers disease clinical trials currently recruiting in Auburn, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Auburn?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Auburn research site will contact you about next steps.

Are clinical trials in Auburn free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Auburn studies also compensate for your time and travel.

What alzheimers disease treatments are being tested?

The 4 active trials in Auburn are testing new therapies including novel drugs, biologics, and treatment approaches for alzheimers disease.

Data updated July 22, 2026 from ClinicalTrials.gov